The article was filed anonymously by a person who identifies self as being short on NNVC stock and calls self “Pump Terminator ... C Rabies Dengue fever and Ebola virus among others. This press release contains forward-looking …
Inno-Haven, LLC, a private company, is controlled by Anil R Diwan, PhD, who is also the President of NanoViricides, …
AOL3y
--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company") announced today that it has raised approximately $20 Million in a registered direct offering ... of NNVC common stock as of Friday, January 17th. …
EXAS closed Tuesday's trading at $36.59, down 1.29%. In after-hours, the stock fell 2.02% to $35.85. Shares of NanoViricides Inc. (NNVC) were up over 38% in extended trading on Tuesday after reporting that its topical shingles …
Action to Take --> --Buy NNVC up to $1.50 -- Set stop-loss at $0.75 -- Set initial price target at $2.50 for a potential 67% gain in six months This article originally appeared at ProfitableTrading.com This Virtually Unknown Stock Could …
“The entire article is of the same character representing defamatory attacks by innuendo, negligent or phony research, and false statements clearly designed to drive the price of NNVC stock lower," the petition says. "This conduct constitutes …
Within the last 200 days, Nanoviricides Inc’s share price has decreased 50.57%; most important is that it’s in steady bear downtrend. Octafinance place NEUTRAL rating on the stock based on our trend-following system which is shown on …
The stock’s market capitalization is 85.78M, it has a 52-week low of 1.03 and a 52-week high of 2.00. The share price of the company (NNVC) was down -1.45%, with a high of 1.43 during the day and the volume of NanoViricides, Inc. shares …
The converted shares are estimated to represent less than five percent of the 10-day trading volume of the Company's …
The top gainer with a security that increased in price during today’s trading was NanoViricides, Inc. (NYSE:NNVC). NanoViricides ... 3.39 exhibiting the investor sentiment on the value of the stock to its actual value. A higher P/B ratio of ...